Citadel Advisors’s Magellan Health Services, Inc. MGLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-11,600
Closed -$1.08M 14819
2021
Q1
$1.08M Buy
11,600
+8,700
+300% +$815K ﹤0.01% 7924
2020
Q4
$240K Sell
2,900
-3,400
-54% -$269K ﹤0.01% 9461
2020
Q3
$477K Sell
6,300
-2,400
-28% -$178K ﹤0.01% 7382
2020
Q2
$635K Sell
8,700
-11,800
-58% -$755K ﹤0.01% 6640
2020
Q1
$986K Buy
+20,500
New +$1.32M ﹤0.01% 5361
2019
Q3
Sell
-6,900
Closed -$512K 10004
2019
Q2
$512K Buy
+6,900
New +$464K ﹤0.01% 6789
2019
Q1
Sell
-5,800
Closed -$330K 10117
2018
Q4
$330K Sell
5,800
-1,200
-17% -$74K ﹤0.01% 7092
2018
Q3
$504K Buy
7,000
+1,300
+23% +$105K ﹤0.01% 6678
2018
Q2
$547K Sell
5,700
-3,300
-37% -$316K ﹤0.01% 6223
2018
Q1
$964K Buy
+9,000
New +$904K ﹤0.01% 4864
2017
Q3
Sell
-3,100
Closed -$226K 8257
2017
Q2
$226K Sell
3,100
-1,200
-28% -$84.3K ﹤0.01% 6373
2017
Q1
$297K Buy
+4,300
New +$314K ﹤0.01% 5896
2016
Q2
Sell
-5,700
Closed -$387K 7611
2016
Q1
$387K Buy
5,700
+5,600
+5,600% +$337K ﹤0.01% 4761
2015
Q4
$6K Buy
+100
New +$5.37K ﹤0.01% 8420
2015
Q3
Sell
-1,300
Closed -$91K 9372
2015
Q2
$91K Buy
1,300
+300
+30% +$20.4K ﹤0.01% 7173
2015
Q1
$71K Sell
1,000
-900
-47% -$56.6K ﹤0.01% 7139
2014
Q4
$114K Buy
1,900
+1,500
+375% +$88.6K ﹤0.01% 6535
2014
Q3
$22K Buy
400
+100
+33% +$5.74K ﹤0.01% 7368
2014
Q2
$19K Buy
300
+100
+50% +$5.88K ﹤0.01% 7321
2014
Q1
$12K Sell
200
-12,000
-98% -$715K ﹤0.01% 7471
2013
Q4
$731K Buy
12,200
+3,200
+36% +$191K ﹤0.01% 3555
2013
Q3
$540K Sell
9,000
-8,300
-48% -$481K ﹤0.01% 3734
2013
Q2
$970K Buy
+17,300
New +$906K ﹤0.01% 3212

Citadel Advisors's MGLN Position: Q1 2022 in Review

Citadel Advisors sold out of Magellan Health Services, Inc. (MGLN) in Q1 2022, closing a stake of 4,107 shares — an estimated $390K sold.

Citadel Advisors first reported a position in MGLN in Q2 2013 and held it in 30 quarters. The position peaked at $21.9M in Q2 2017. 0 funds tracked by Wall St. Rank hold MGLN as of Q1 2022.

  • Citadel Advisors reported no remaining Magellan Health Services, Inc. position as of Q1 2022 after selling out during the quarter.
  • Citadel Advisors sold 4,107 Magellan Health Services, Inc. shares in Q1 2022, an estimated $390K.
  • Citadel Advisors first reported a position in Magellan Health Services, Inc. in Q2 2013 and held it in 30 quarters.
  • Citadel Advisors's Magellan Health Services, Inc. position peaked at $21.9M in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Magellan Health Services, Inc. as of Q1 2022.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.